Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
What's hidden in plain sight? Impact of clonal hematopoiesis on the risk and progression of non-hematologic cancers.
Haematologica
September 2025
Department of Medicine, University of California Irvine Health, Orange, CA.
Clonal hematopoiesis (CH) is a frequently observed phenomenon in aging individuals without apparent illness and exhibits an increased prevalence in cancer patients. Mechanistic studies indicate that mutant immune cells alter the tumor microenvironment, leading to increased inflammation, blood vessel formation, and immune cell exhaustion. Paradoxically, these changes also preserve stem-like T-cell pools that can be utilized by immunotherapy.
View Article and Find Full Text PDFOptimizing cystectomy outcomes in muscle-invasive bladder cancer: what's new in 2025?
Expert Rev Anticancer Ther
July 2025
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Introduction: Radical cystectomy (RC) remains the gold standard surgical treatment for muscle-invasive bladder cancer (MIBC). It is a technically complex procedure with considerable short- and long-term morbidity, even in experienced hands.
Areas Covered: This review highlights recent advances in the multidisciplinary management of MIBC across the pre-, peri-, and post-operative phases.
[What's new in oncologic plastic surgery in 2025?].
Ann Chir Plast Esthet
July 2025
Department of Plastic and Reconstructive Surgery, Institut Universitaire Locomoteur et du Sport, Pasteur 2 Hospital, University Côte d'Azur, Nice, France; Laboratory of Molecular PhysioMedicine (LP2M), UMR 7370, CNRS, University Côte d'Azur, Nice, France. Electronic address:
Introduction: Oncological plastic surgery plays a central role in the management of cancers requiring complex reconstruction. Recent years have seen significant advances in oncology, both therapeutic and technological. The aim of this article is to provide an overview of major recent developments in oncological plastic surgery, through a selection of impactful recent studies chosen by national experts in three of the main fields of this specialty.
View Article and Find Full Text PDFRespiratory syncytial virus immunization in children: The old, the new and what's just around the corner.
Hum Vaccin Immunother
December 2025
Department of Neonatology, Hospital Clinic, Barcelona, Spain.
Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory tract infection, hospitalization, morbidity and mortality in young children. This review summarizes current RSV immunization strategies and parental perspectives on their use. Until recently, immunization was limited to high-risk infants and children, including those born prematurely or with significant co-morbidities, monthly dosing with the monoclonal antibody (mAb) palivizumab.
View Article and Find Full Text PDFA Critical Review of CAR-T Therapies for Glioblastoma: What's Wrong with the Current Attempts?
Hematol Oncol Stem Cell Ther
July 2025
National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia.
Today, CAR-T therapy has been widely acknowledged as a "gold standard" treatment for certain hematologic diseases. There is a relatively small but enhancing body of clinical trials studying the effectiveness of CAR-T in treating glioblastoma, known as the most common and aggressive brain tumor in adults. Despite the promising findings, currently available data is still erratic.
View Article and Find Full Text PDF